IGF1 and colorectal carcinoma: Longer telomeres appear to promote IGF1 production, which subsequently enhances CRC risk through well-characterized oncogenic pathways, including enhanced cell proliferation, apoptosis resistance, and angiogenesis promotion [39, 40].